Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics Guidance for Industry JUNE 2024Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics Guidance for Industry JUNE 2024

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacology-considerations-development-oligonucleotide-therapeutics?utm_medium=email&utm_source=govdelivery